Temasek emerges as the frontrunner to buy stake in Intas Pharma from ChrysCap

Premium

Singapore’s sovereign fund Temasek Holdings has emerged as the front runner in the race to acquire a little over 10 per cent stake in Ahmedabad-based Intas Pharmaceuticals from existing private equity investor ChrysCapital for approximately Rs 840 crore, sources close to the deal told VCCircle.The deal, which would see ChrysCap ......